Epoch Investment Partners, Inc. Incyte Corp Transaction History

Epoch Investment Partners, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $252,344 - $317,165	3,813 Added 3.29%	119,707 $9.09 Million
Q4 2021 Feb 11, 2022	BUY	$63.34 - $74.11 $174,691 - $204,395	2,758 Added 2.44%	115,894 $8.51 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $7.77 Million - $9.51 Million	113,136 New	113,136 $7.78 Million
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $387,688 - $424,870	4,854 Added 1.64%	300,109 $25.2 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $6.07 Million - $8.03 Million	79,873 Added 37.08%	295,255 $24 Million
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $13.6 Million - $16.4 Million	-167,970 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $1.47 Million - $1.9 Million	17,331 Added 11.5%	167,970 $15.1 Million
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $11.2 Million - $16.4 Million	150,639 New	150,639 $15.7 Million

706

189M

909K

489K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Epoch Investment Partners, Inc. with notifications on news.